Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria

Parasitology Today

Volumn 12, Issue 10, 1996, Pages 399-401

  White, Nick J ^a,b   Olliaro, Piero L ^c  

^a MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^b CHO QUAN HOSPITAL   (Viet Nam)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ATOVAQUONE; CHLOROQUINE; DOXYCYCLINE; HALOFANTRINE; PYRIMETHAMINE; PYRONARIDINE; QUININE; SULFONAMIDE; TETRACYCLINE;

DRUG COMBINATION; DRUG RESISTANCE; HUMAN; MALARIA; REVIEW; THERAPY;

CINCHONA PUBESCENS;

EID: 0030271322     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-4758(96)10055-7     Document Type: Article

References (42)

1. 1 Hien, T.T. and White, N.J. (1993) Qinghaosu. Lancet 341, 603-608
2. 2 Anon. (1994) Artemisinin. Trans. R. Soc. Trop. Med. Hyg. 88 (Suppl. 2), 1-65
3. 3 World Health Organization (1994) Report of an informal consultation, Geneva 14-17 March 1994. WHO/MAL/94. 1070, WHO
4. 4 Björkman, A. and Philipps-Howard, P.A. (1990) The epidemiology of drug-resistant malaria. Trans. R. Soc. Trop. Med. Hyg. 84, 177-180
5. 5 Wernsdorfer, W.H. (1991) The development and spread of drug-resistant malaria. Parasitol. Today 7, 297-303
6. 6 White, N.J. (1992) Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30, 571-585
7. 7 Looareesuwan, S. et al. (1992) Drug resistant malaria with special reference to Thailand. Southeast Asian J. Trop. Med. Public Health 23, 621-634
8. 8 Brasseur, P. et al. (1990) Emergence of mefloquine resistant malaria in Africa in the absence of drug pressure. Lancet 59, 336-359
9. 9 Brasseur, P. et al. (1992) Multidrug resistant falciparum malaria in Cameroun in 1987-1988 II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance. Am. J. Trop. Med. Hyg. 46, 8-14
10. 10 Nosten, F. et al. (1991) Mefloquine-resistant falciparum malaria in the Thai-Burmese border. Lancet 337, 1140-1143
11. 11 Fontanet, A.L. et al. (1993) High prevalence of mefloquine-resistant falciparum malaria in Eastern Thailand. Bull. WHO 71, 377-383
12. 12 Basco, L.K. et al. (1991) Type RI resistance to halofantrine in West Africa. Trop. Med. Parasitol. 42, 413-414
13. 13 Brasseur, P. et al. (1993) Fast emergence of Plasmodium falciparum resistance to halofantrine. Lancet 341, 901-902
14. 14 ter Kuile, F.O. et al. (1993) Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet 341 (8852), 1044-1049
15. 15 Looareesuwan, S. et al. (1996). Clinical studies of atovaquone alone and in combination with other antimalarial drugs for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54, 62-66
16. 16 Rieckmann, K.H., Davis, D.R. and Hutton, D.C. (1989) Plasmodium vivax resistance to chloroquine? Lancet ii, 1183-1184
17. 17 Murphy, G.S. et al. (1993) Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341, 96-100
18. 18 Pukrittayakamee, S. et al. (1994) Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans. R. Soc. Trop. Med. Hyg. 88, 324-327
19. 19 Shapira, A., Beales, P.F. and Halloran, M.E. (1993) Malaria: living with drug resistance. Parasitol. Today 9, 168-171
20. 20 Foster, S. (1991) Supply and use of essential drugs in subsaharan Africa: Some issues and possible solutions. Soc. Sci. Med. 32, 1201-1218
21. 21 McCombie, S.C. (1994) Treatment seeking for malaria: a review and suggestions for future research. Resource Paper No. 2. Social and Economic Research in Tropical Diseases. UNDP/ World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). TDR/SER/RP/94.1
22. 22 Watkins, W.M. and Mosobo, M. (1993) Treatment of Plasmodium falciparum malaria with PSD: selective pressure for resistance is a function of long elimination half life. Trans. R. Soc. Trop. Med. Hyg. 87, 75-78
23. 23 Peterson, D.S., Milhous, W.K. and Wellems, T.E. (1990) Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. U.S.A. 87, 3018-3022
24. 24 Sirawaraporn, W. et al. (1993) Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. J. Biol. Chem. 268, 21637-21644
25. 25 Peters, W. (1987) Chemotherapy and Drug Resistance in Malaria, 2nd edn, Academic Press
26. 26 Bickerton-Blackburn, C. (1948) Observations on the development of resistance to vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 42, 117-162
27. 27 White, N.J. (1987) Combination treatment for falciparum prophylaxis. Lancet i, 1261
28. 28 Grosset, J. (1980) Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin. Chest Med. 1, 231-234
29. 29 David, H.L. (1970) Probability distribution of drug-resistant mutants in unselected populations of M. tuberculosis. Appl. Microbiol. 20, 810-814
30. 30 Garcia-Vidal, J. et al. (1989) Evolution of resistance of Plasmodium falciparum to antimalarial drugs in Rwanda 1985-1987. Trans. R. Soc. Trop. Med. Hyg. 83, 490
31. 31 Lege-Oguntoye, L. et al. (1990) Resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine combination in semiimmune children in Zaria, northern Nigeria. Trans. R. Soc. Trop. Med. Hyg. 84, 505-509
32. 32 Peters, W. and Robinson, B.L. (1984) The chemotherapy of rodent malaria XXXV: Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and "P. berghei NS". Ann. Trop. Med. Parasitol. 78, 459-466
33. 33 Shao, B.R. et al. (1989) Antimalarial and toxic effect of triple combination of pyronaridine, sulfadoxine and pyrimethamine. Southeast Asian J. Trop. Med. Public Health 20, 257-263
34. 34 Kremsner, P.G. et al. (1988) A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil. J. Infect. Dis. 158, 1368-1371
35. 35 Canfield, C.J., Pudney, M. and Gutteridge, W.E. (1995) Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80, 373-381
36. 36 Canfield C.J. et al. (1995) World-wide controlled clinical trials with atovaquone and proguanil for treatment of Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 53, 87
37. 37 Looareesuwan, S. et al. (1992) Randomised trail of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 339, 821-824
38. 38 Looareesuwan, S. et al. (1994) Treatment of patients with recrudescent falciparum malaria with sequential combinations of artesunate and mefloquine. Am. J. Trop. Med. Hyg. 47, 794-799
39. 39 Luxemburger, C. et al. (1994) Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 88, 213-217
40. 40 Karbwang, J. et al. (1995) A comparative clinical trial of two different regimens of artemether plus mefloquine in multidrug resistant malaria. Trans. R. Soc. Trop. Med. Hyg. 89, 290-298
41. 41 Price, R.N. et al. (1995) Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 89, S23-S27
42. 42 Nosten, F. et al. (1994) Treatment of multidrug resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 170, 971-977